Mark D. Pegram

机构：Stanford University · ORCID：0000-0002-9743-8118

发表论文 421 篇 · 总被引 42099 次 · h-index 67

代表论文

• Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial (2025 · Journal of Clinical Oncology · 被引 8)
• Real-World Outcomes of Elacestrant in ER+, HER2−, ESR1 -Mutant Metastatic Breast Cancer (2025 · Clinical Cancer Research · 被引 8)
• Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2− Advanced Breast Cancer (2025 · Oncology and Therapy · 被引 2)
• Ferrous Iron Accumulation Is a Hallmark and Therapeutic Vulnerability of Therapy-Induced Senescence (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Spontaneous upregulation of stemness and 3D spheroid formation of single cancer cells induced by scaffold-free polypeptide polyelectrolyte multilayer coating (2025 · Biomaterials · 被引 1)
• Etirinotecan Pegol ( NKTR ‐102) in Patients With Active Brain Metastases From Lung or Breast Cancer (2025 · Cancer Reports · 被引 1)